You are using an outdated browser. Please upgrade your browser to improve your experience.

aminopterin/methotrexate embryofetopathy

Disease Summary
Associated Targets ()

Mondo Description Aminopterin/Methotrexate embryofetopathy is a syndrome of developmental anomalies characterized by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.
Mondo Term and Equivalent IDs
MONDO:0016004:  aminopterin/methotrexate embryofetopathy
GARD:0002294: 
NCIT:C98928: 
Orphanet:1908: 
SCTID:65986000: 
UMLS:C0432367: